Skip to main content
Top
Published in: World Journal of Pediatrics 3/2020

Open Access 01-06-2020 | Patent Ductus Arteriosus | Original Article

Perinatal risk factors for pulmonary hemorrhage in extremely low-birth-weight infants

Authors: Ting-Ting Wang, Ming Zhou, Xue-Feng Hu, Jiang-Qin Liu

Published in: World Journal of Pediatrics | Issue 3/2020

Login to get access

Abstract

Background

Pulmonary hemorrhage (PH) is a life-threatening respiratory complication of extremely low-birth-weight infants (ELBWIs). However, the risk factors for PH are controversial. Therefore, the purpose of this study was to analyze the perinatal risk factors and short-term outcomes of PH in ELBWIs.

Methods

This was a retrospective cohort study of live born infants who had birth weights that were less than 1000 g, lived for at least 12 hours, and did not have major congenital anomalies. A logistic regression model was established to analyze the risk factors associated with PH.

Results

There were 168 ELBWIs born during this period. A total of 160 infants were included, and 30 infants were diagnosed with PH. Risk factors including gestational age, small for gestational age, intubation in the delivery room, surfactant in the delivery room, repeated use of surfactant, higher FiO2 during the first day, invasive ventilation during the first day and early onset sepsis (EOS) were associated with the occurrence of PH by univariate analysis. In the logistic regression model, EOS was found to be an independent risk factor for PH. The mortality and intraventricular hemorrhage rate of the group of ELBWIs with PH were significantly higher than those of the group of ELBWIs without PH. The rates of periventricular leukomalacia, moderate-to-severe bronchopulmonary dysplasia and severe retinopathy of prematurity, and the duration of the hospital stay were not significantly different between the PH and no-PH groups.

Conclusions

Although PH did not extend hospital stay or increase the risk of bronchopulmonary dysplasia, it increased the mortality and intraventricular hemorrhage rate in ELBWIs. EOS was the independent risk factor for PH in ELBWIs.
Literature
1.
go back to reference Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med. 1999;7:715–21.CrossRef Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med. 1999;7:715–21.CrossRef
2.
go back to reference Ferreira CH, Carmona F, Martinez FE. Prevalence, risk factors and outcomes associated with pulmonary hemorrhage in newborns. J Pediatr. 2014;90:316–22.CrossRef Ferreira CH, Carmona F, Martinez FE. Prevalence, risk factors and outcomes associated with pulmonary hemorrhage in newborns. J Pediatr. 2014;90:316–22.CrossRef
3.
go back to reference Chen YY, Wang HP, Lin SM, Chang JT, Hsieh KS, Huang FK, et al. Pulmonary hemorrhage in very low-birthweight infants: Risk factors and management. Pediatr Int. 2012;54:743–7.CrossRef Chen YY, Wang HP, Lin SM, Chang JT, Hsieh KS, Huang FK, et al. Pulmonary hemorrhage in very low-birthweight infants: Risk factors and management. Pediatr Int. 2012;54:743–7.CrossRef
4.
go back to reference Yen TA, Wang CC, Hsieh WS, Chou HC, Chen CY, Tsao PN. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants. Pediatr Neonatol. 2013;54:330–4.CrossRef Yen TA, Wang CC, Hsieh WS, Chou HC, Chen CY, Tsao PN. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants. Pediatr Neonatol. 2013;54:330–4.CrossRef
5.
go back to reference Battin MR, Knight DB, Kuschel CA, Howie RN. Improvement in mortality of very low birthweight infants and the changing pattern of neonatal mortality: the 50-year experience of one perinatal centre. J Paediatr Child Health. 2012;48:596–9.CrossRef Battin MR, Knight DB, Kuschel CA, Howie RN. Improvement in mortality of very low birthweight infants and the changing pattern of neonatal mortality: the 50-year experience of one perinatal centre. J Paediatr Child Health. 2012;48:596–9.CrossRef
6.
go back to reference Lin TW, Su BH, Lin HC, Hu PS, Peng CT, Tsai CH, et al. Risk factors of pulmonary hemorrhage in very low birth weight infants: a two-year retrospective study. Acta Pediatr Taiwan. 2000;41:255–8. Lin TW, Su BH, Lin HC, Hu PS, Peng CT, Tsai CH, et al. Risk factors of pulmonary hemorrhage in very low birth weight infants: a two-year retrospective study. Acta Pediatr Taiwan. 2000;41:255–8.
7.
go back to reference Sola A, Kurlat I, Pollak A, Devlieger H, Tapia J, Saenz A, et al. Early versus delayed neonatal administration of a synthetic surfactant: the judgment of OSIRIS. Lancet. 1992;340:1363–9.CrossRef Sola A, Kurlat I, Pollak A, Devlieger H, Tapia J, Saenz A, et al. Early versus delayed neonatal administration of a synthetic surfactant: the judgment of OSIRIS. Lancet. 1992;340:1363–9.CrossRef
8.
go back to reference Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000;137:68–72.CrossRef Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000;137:68–72.CrossRef
9.
go back to reference Chen D, Wang M, Wang X, Ding XW, Ba RH, Mao J. High-risk factors and clinical characteristics of massive pulmonary hemorrhage in infants with extremely low birth weight. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:54–8.PubMed Chen D, Wang M, Wang X, Ding XW, Ba RH, Mao J. High-risk factors and clinical characteristics of massive pulmonary hemorrhage in infants with extremely low birth weight. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:54–8.PubMed
10.
go back to reference Dawson JA, Kamlin CO, Vento M, Wong C, Cole TJ, Donath SM, et al. Defining the reference range for oxygen saturation for infants after birth. Pediatrics. 2010;125:1340–7.CrossRef Dawson JA, Kamlin CO, Vento M, Wong C, Cole TJ, Donath SM, et al. Defining the reference range for oxygen saturation for infants after birth. Pediatrics. 2010;125:1340–7.CrossRef
11.
go back to reference Sankar MN, Bhombal S, Benitz WE. PDA: to treat or not to treat. Congenit Heart Dis. 2019;14:46–51.CrossRef Sankar MN, Bhombal S, Benitz WE. PDA: to treat or not to treat. Congenit Heart Dis. 2019;14:46–51.CrossRef
12.
go back to reference Suryawanshi P, Nagpal R, Meshram V, Malshe N, Kalrao V. Pulmonary hemorrhage (PH) in extremely low birth weight (ELBW) Infants: successful treatment with surfactant. J Clin Diagn Res. 2015;9:3–4. Suryawanshi P, Nagpal R, Meshram V, Malshe N, Kalrao V. Pulmonary hemorrhage (PH) in extremely low birth weight (ELBW) Infants: successful treatment with surfactant. J Clin Diagn Res. 2015;9:3–4.
13.
go back to reference Su BH, Lin HY, Huang FK, Tsai ML, Huang YT. Circulatory management focusing on preventing intraventricular hemorrhage and pulmonary hemorrhage in preterm infants. Pediatr Neonatol. 2016;57:453–62.CrossRef Su BH, Lin HY, Huang FK, Tsai ML, Huang YT. Circulatory management focusing on preventing intraventricular hemorrhage and pulmonary hemorrhage in preterm infants. Pediatr Neonatol. 2016;57:453–62.CrossRef
14.
go back to reference Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics. 2008;121:233–8.CrossRef Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics. 2008;121:233–8.CrossRef
15.
go back to reference Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremelylow birth weight infants. Neonatology. 2013;103:166–9.CrossRef Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremelylow birth weight infants. Neonatology. 2013;103:166–9.CrossRef
16.
go back to reference Adrouche-Amrani L, Green RS, Gluck KM, Lin J. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants. BMC Pediatr. 2012;12:10. Adrouche-Amrani L, Green RS, Gluck KM, Lin J. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants. BMC Pediatr. 2012;12:10.
17.
go back to reference Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2019;6:CD004213.PubMed Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2019;6:CD004213.PubMed
18.
go back to reference Stephens BE, Gargus RA, Walden RV, Mance M, Nye J, McKinley L, et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2008;28:123–8.CrossRef Stephens BE, Gargus RA, Walden RV, Mance M, Nye J, McKinley L, et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2008;28:123–8.CrossRef
19.
go back to reference Yum SK, Moon CJ, Youn YA, Lee HS, Kim SY, Sung IK. Risk factor profile of massive pulmonary haemorrhage in neonates: the impact on survival studied in a tertiary care centre. J Matern Fetal Neonatal Med. 2016;29:338–43.CrossRef Yum SK, Moon CJ, Youn YA, Lee HS, Kim SY, Sung IK. Risk factor profile of massive pulmonary haemorrhage in neonates: the impact on survival studied in a tertiary care centre. J Matern Fetal Neonatal Med. 2016;29:338–43.CrossRef
20.
go back to reference Polglase GR, Kluckow M, Gill AW, Allison BJ, Moss TJ, Dalton RGB, et al. Cardiopulmonary haemodynamics in lambs during induced capillary leakage immediately after preterm birth. Clin Exp Pharmacol Physiol. 2011;38:222–8.CrossRef Polglase GR, Kluckow M, Gill AW, Allison BJ, Moss TJ, Dalton RGB, et al. Cardiopulmonary haemodynamics in lambs during induced capillary leakage immediately after preterm birth. Clin Exp Pharmacol Physiol. 2011;38:222–8.CrossRef
21.
go back to reference West JB, Mathieu-Costello O. Stress failure of pulmonarycapillaries: role in lung and heart disease. Lancet. 1992;340:762–8.CrossRef West JB, Mathieu-Costello O. Stress failure of pulmonarycapillaries: role in lung and heart disease. Lancet. 1992;340:762–8.CrossRef
22.
go back to reference Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, et al. Neonatal Research Network. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786–90.CrossRef Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, et al. Neonatal Research Network. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786–90.CrossRef
23.
go back to reference Bozdağ Ş, Dilli D, Gökmen T, Dilmen U. Comparison of two natural surfactants for pulmonary hemorrhage in very low-birth-weight infants: a randomized controlled trial. Am J Perinatol. 2015;32:211–8.CrossRef Bozdağ Ş, Dilli D, Gökmen T, Dilmen U. Comparison of two natural surfactants for pulmonary hemorrhage in very low-birth-weight infants: a randomized controlled trial. Am J Perinatol. 2015;32:211–8.CrossRef
24.
go back to reference Strauss T, Rozenzweig N, Rosenberg N, Shenkman B, Livnat T, Morag I, et al. Surfactant impairs coagulation in-vitro: a risk factor for pulmonary hemorrhage? Thromb Res. 2013;132:599–603.CrossRef Strauss T, Rozenzweig N, Rosenberg N, Shenkman B, Livnat T, Morag I, et al. Surfactant impairs coagulation in-vitro: a risk factor for pulmonary hemorrhage? Thromb Res. 2013;132:599–603.CrossRef
25.
go back to reference Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev. 2012;7:CD005254. Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev. 2012;7:CD005254.
26.
go back to reference Jeon GW, Oh M, Sin JB. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study. Yonsei Med J. 2015;56:433–9.CrossRef Jeon GW, Oh M, Sin JB. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study. Yonsei Med J. 2015;56:433–9.CrossRef
Metadata
Title
Perinatal risk factors for pulmonary hemorrhage in extremely low-birth-weight infants
Authors
Ting-Ting Wang
Ming Zhou
Xue-Feng Hu
Jiang-Qin Liu
Publication date
01-06-2020
Publisher
Springer Singapore
Published in
World Journal of Pediatrics / Issue 3/2020
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-019-00322-7

Other articles of this Issue 3/2020

World Journal of Pediatrics 3/2020 Go to the issue